Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
19.1M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
2.04M
-
Shares change
-
-39.4K
-
Total reported value, excl. options
-
$13M
-
Value change
-
-$274K
-
Put/Call ratio
-
0.03
-
Number of buys
-
6
-
Number of sells
-
-8
-
Price
-
$6.37
Significant Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q1 2022
26 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value as of Q1 2022.
enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.04M shares
of 19.1M outstanding shares and own 10.65% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (782K shares), ACT CAPITAL MANAGEMENT, LLC (401K shares), VANGUARD GROUP INC (279K shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (219K shares), GEODE CAPITAL MANAGEMENT, LLC (80K shares), Kepos Capital LP (50K shares), TWO SIGMA ADVISERS, LP (49.6K shares), BlackRock Inc. (38.4K shares), MORGAN STANLEY (36K shares), and TWO SIGMA INVESTMENTS, LP (33.4K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.